Diagnos (ADK) announces engagement of Allele Capital
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/24/2026
- Wall Street ends down as oil prices, Treasury yields rise
- BTIG’s Krinsky warns 2000-like signals are mounting
- HSBC remains max bullish on stocks, tells investors to lean into tech
- Analyst explains why the midterm outcome is a “fundamental non-event”
- Oil settles up around 4% as Iran's president vows to never surrender
- Anthropic's Claude AI identifies novel enzyme system in DNA search
- Wall Street ends down as oil prices, Treasury yields rise
- AppLovin (APP) on watch amid 3% drop premarket as boutique comments circulate
- Plug Power COO resigns to join another company
- Xtend AI Robotics wins Phase III of USSOCOM lethal drone program
DIAGNOS Announces the Engagement of Allele Capital Partners
May 23, 2025 12:02 PM EDTBROSSARD, Quebec, May 23, 2025 (GLOBE NEWSWIRE) -- Diagnos Inc. (DIAGNOS or the Corporation) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a pioneer in early detection of critical health issues using advanced technology based on Artificial Intelligence (AI), announces the engagement of Allele Capital Partners, LLC (Allele) to provide capital markets advisory and social media services to the Corporation.
As per the agreement signed between Allele and DIAGNOS, Allele is entitled to a monthly compensation of US$7,500, payable in advance in cash, for the period of May 22, 2025 to August 22, 2025 (the Trial Period).... More
